Latest News

Latest News

News from the World Hepatitis Alliance

Highlighting the importance of patient advocacy at international conferences

31 Mar 2015 Bridie Taylor

24th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Istanbul, Turkey, 12 – 15 March Patient led advocacy is vital in...

How will 2015 be a defining year for the Alliance?

28 Feb 2015 Bridie Taylor

Viral hepatitis is a global killer with alarming mortality rates, yet an increased global commitment to tackling the disease and ground-breaking new...

How does the Alliance really represent hepatitis patients?

28 Feb 2015 Bridie Taylor

The World Hepatitis Alliance prides itself as the true voice of hepatitis patients living all over the world. All our work is overseen by an...

What is the future for hepatitis treatments? And how we can fund hepatitis programmes?

28 Feb 2015 Bridie Taylor

Discussions around hepatitis are dominated by the pioneering new treatments rapidly transforming the landscape and the ensuing heated discussions...

Need some inspiration for action? : Initiatives from WHA members

28 Feb 2015 Bridie Taylor

Together our voices are stronger and united we can tackle this global killer! The World Hepatitis Alliance is fortunate enough to be made up of...

WHA in official relations with WHO: What does this mean for you?

28 Feb 2015 Bridie Taylor

Fundamental to our ability to influence global hepatitis policy and bring about real change in the world of hepatitis is our relationship with the...

Assisting WHO in the development of a global strategy

31 Jan 2015 Bridie Taylor

World Health Organization Member States have urged WHO to develop a comprehensive global strategy on hepatitis. To assist in the development of this...

World Hepatitis Alliance’s ever-growing membership base

31 Jan 2015 Bridie Taylor

Central to the success of the World Hepatitis Alliance are our member groups around the world. To stimulate political interest in and action on...

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...

Pages

News from infohep

Fatty liver raises the risk of death in people with HIV and hepatitis C

15 Sep 2019 Keith Alcorn
People with HIV and hepatitis C co-infection who had fatty liver disease were twice as likely to die during a five-year follow-up period as their...

Does hepatitis C virus remain in the body after successful treatment?

11 Sep 2019 Keith Alcorn
Persistence of very low-level hepatitis C infection after a sustained virologic response to hepatitis C treatment is an extremely rare event and is...

Curing hepatitis C may reduce inflammation in people with HIV

11 Sep 2019 Liz Highleyman
Successful treatment of hepatitis C virus (HCV) may lead to a reduction in immune activation related to leakage of bacteria from the gut in people...

FDA warns of rare cases of serious liver injury with newer hepatitis C drugs

29 Aug 2019 Keith Alcorn
The US Food and Drug Administration (FDA) has issued a warning about the risk of serious liver injury in people with hepatitis C after starting...

Voluntary licensing of hepatitis C drugs has led to more people on treatment

28 Aug 2019 Keith Alcorn
Voluntary licensing of hepatitis C treatments to generic drug manufacturers for sale in lower- and middle-income countries has increased the number...

US doctors failing to diagnose hepatitis C years after first signs of cirrhosis

23 Aug 2019 Keith Alcorn
Doctors are failing to test for hepatitis C in up to one in five people who have advanced liver disease despite many years of medical care, and...

Hepatitis B raises the risk of some cancers

12 Aug 2019 Keith Alcorn
Chinese people with chronic hepatitis B infection had an increased risk of several digestive system cancers, especially stomach cancer, researchers...

Young adults with vertical HIV and hepatitis C co-infection have a high hepatitis C cure rate

8 Aug 2019 Liz Highleyman
Young adults with vertically transmitted HIV and hepatitis C virus (HCV) co-infection can easily be cured with direct-acting antivirals (DAAs),...

13% of HIV-positive Europeans who are cured of hepatitis C are reinfected

5 Aug 2019 Liz Highleyman
More than one in ten HIV-positive people in the large EuroSIDA cohort who were cured of hepatitis C were reinfected within two years, according to...

Hepatitis C does not raise risk of heart disease or cancers in people with HIV

18 Jul 2019 Keith Alcorn
Hepatitis C co-infection does not increase the risk of cardiovascular disease or non-AIDS cancers in people with HIV, an analysis of the large...